Unaudited Consolidated Balance Sheets - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 37,589	$ 165,546
Accounts receivable	6,050	2,846
Other current assets	1,989	2,522
Total current assets	45,628	170,914
Patents, net of accumulated amortization of $983,850 and $650,560, respectively	2,150,048	2,463,338
Total assets	2,195,676	2,634,252
Current liabilities:
Accounts payable and accrued liabilities	233,623	147,356
Loans payable - third party	163,000	163,000
Purchase price of patents, current portion	100,000	100,000
Loan payable - related party, net of unamortized discount and debt issuance costs of $418,866 and $517,182, respectively	3,858,485	3,510,169
Accrued interest - loans payable related party	395,459	85,757
Accrued interest - loans payable third party	277,439	265,214
Derivative liability	115,000	90,000
Total current liabilities	5,143,006	4,361,496
Non-current liabilities
Purchase price of patents, current portion, net of unamortized discount of $123,321 and $175,243, respectively	751,679	699,757
Total liabilities	5,894,685	5,061,253
Stockholders' deficit:
Preferred stock - par value $.00003 per share - authorized 10,000,000 Shares - no shares issued and outstanding
Common stock, par value $0.00003 per share; authorized 10,000,000,000 shares at September 30, 2018 and December 31, 2017, shares issued and outstanding 383,038,334 and 383,038,334, at September 30, 2018 and December 31, 2017	11,491	11,491
Additional paid-in capital	14,107,782	14,107,782
Accumulated deficit	(17,819,990)	(16,549,493)
Total Quest Patent Research Corporation deficit	(3,700,717)	(2,430,220)
Non-controlling interest in subsidiary	1,708	3,219
Total stockholders' deficit	(3,699,009)	(2,427,001)
Total liabilities and stockholders' deficit	$ 2,195,676	$ 2,634,252